Member access

4-Traders Homepage  >  Shares  >  Toronto Stock Exchange  >  Cardiome Pharma Corp.    COM   CA14159U3010

SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Engages in the discovery, development and commercialization of new therapies

Cardiome Pharma Corp. is a biopharmaceutical company, which engages in the discovery, development and commercialization of new therapies that will improve the health of patients around the world.

Its product BrinavessTM approved in Europe and other territories for the rapid conversion of recent onset atrial fibrillation to sinus rhythm in adults.

Cardiome Pharma was founded on December 12, 1986 and is headquartered in Vancouver, Canada.
Sales per Businesses
20122013Delta
CAD (in Million)%CAD (in Million)%
Pharma Prod Dev0.789100%4.65100% +83.03%
Sales per Regions
2013
CAD (in Million)%
Rest of the World2.6957.9%
Europe1.9542.1%
Surperformance© rating of Cardiome Pharma Corp.
Overall rating In sector In country
Trading Rating
Investor Rating
Growth (Revenue)
Valuation - - -
Finances - - -
Profitability
Earnings quality
Business Predictability
PER - - -
Potential
Yield - - -
Consensus
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
More Ratings
Sector
Healthcare
Biotechnology / Pharmaceuticals
 Biotechnology / Pharmaceuticals
  Biotechnology
Advertisement
Sector Biotechnology
Trading RatingInvestor Rating
GILEAD SCIENCES, ..
AMGEN, INC.
BIOGEN IDEC INC
CELGENE CORPORATI..
CSL LIMITED
Sector Biotechnology
Company contact information
Cardiome Pharma Corp.
6190 Agronomy Road
Suite 405
Vancouver, BC V6T 1Z3

Phone : +1.604.677.6905
Fax : +1.604.677.6915
Web : www.cardiome.com
© 2014 Factset   
Dynamic quotes  
ON
| OFF